![Akhila Kosaraju](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Akhila Kosaraju
Geen lopende functies
Profiel
Akhila Kosaraju was the founder of Variant Bio, Inc. which was founded in 2018, where she held the title of President.
She also worked as Vice President-Global Development at SIGA Technologies, Inc.
Eerdere bekende functies van Akhila Kosaraju
Bedrijven | Functie | Einde |
---|---|---|
Variant Bio, Inc.
![]() Variant Bio, Inc. BiotechnologyHealth Technology Variant Bio, Inc. is a biotechnology company, which engages in the development of new generation of therapeutics. It focuses on traits of medical relevance and using genomics. The company was founded by Akhila Kosaraju, Kaja Wasik, and Stephane Castel in 2018 and is headquartered in New York, NY. | Oprichter | - |
SIGA TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SIGA TECHNOLOGIES, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Variant Bio, Inc.
![]() Variant Bio, Inc. BiotechnologyHealth Technology Variant Bio, Inc. is a biotechnology company, which engages in the development of new generation of therapeutics. It focuses on traits of medical relevance and using genomics. The company was founded by Akhila Kosaraju, Kaja Wasik, and Stephane Castel in 2018 and is headquartered in New York, NY. | Health Technology |